Cargando…
HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival
Over the past four decades there have been minimal improvements in outcomes for patients with osteosarcoma. New targets and novel therapies are needed to improve outcomes for these patients. We sought to evaluate the prevalence and clinical significance of the newest immune checkpoint, HHLA2, in ost...
Autores principales: | Koirala, Pratistha, Roth, Michael E., Gill, Jonathan, Chinai, Jordan M., Ewart, Michelle R., Piperdi, Sajida, Geller, David S., Hoang, Bang H., Fatakhova, Yekaterina V., Ghorpade, Maya, Zang, Xingxing, Gorlick, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987662/ https://www.ncbi.nlm.nih.gov/pubmed/27531281 http://dx.doi.org/10.1038/srep31154 |
Ejemplares similares
-
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
por: Koirala, Pratistha, et al.
Publicado: (2016) -
CD49b inhibits osteogenic differentiation and plays an important role in osteosarcoma progression
por: Ren, Tingting, et al.
Publicado: (2017) -
The effect of bone morphogenetic protein-2 on osteosarcoma metastasis
por: Gill, Jonathan, et al.
Publicado: (2017) -
Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma
por: Poon, Vincent I, et al.
Publicado: (2015) -
Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma
por: Zhang, Yidan, et al.
Publicado: (2018)